Enhanced prefrontal nicotinic signaling as evidence of active compensation in Alzheimer’s disease models

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Enhanced prefrontal nicotinic signaling as evidence of active compensation in Alzheimer’s disease models ; volume:13 ; number:1 ; day:3 ; month:12 ; year:2024 ; pages:1-15 ; date:12.2024
Translational neurodegeneration ; 13, Heft 1 (3.12.2024), 1-15, 12.2024

Creator
Power, Saige K.
Venkatesan, Sridevi
Qu, Sarah
McLaurin, JoAnne
Lambe, Evelyn K.
Contributor
SpringerLink (Online service)

DOI
10.1186/s40035-024-00452-7
URN
urn:nbn:de:101:1-2502172104577.280824134175
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Power, Saige K.
  • Venkatesan, Sridevi
  • Qu, Sarah
  • McLaurin, JoAnne
  • Lambe, Evelyn K.
  • SpringerLink (Online service)

Other Objects (12)

Active immunotherapy options for Alzheimer’s disease

Active immunotherapy options for Alzheimer’s disease

Polymorphisms of nicotinic acetylcholine receptors in Alzheimer’s disease: a systematic review and data analysis

Polymorphisms of nicotinic acetylcholine receptors in Alzheimer’s disease: a systematic review and data analysis

Alzheimer’s disease candidate gene PION is differentially expressed in human prefrontal cortex

Alzheimer’s disease candidate gene PION is differentially expressed in human prefrontal cortex

Variability and compensation in Alzheimer‘s disease across different neuronal network scales

Variability and compensation in Alzheimer‘s disease across different neuronal network scales

Disrupted pursuit compensation during self-motion perception in early Alzheimer’s disease

Disrupted pursuit compensation during self-motion perception in early Alzheimer’s disease

Different peripheral expression patterns of the nicotinic acetylcholine receptor in dementia with Lewy bodies and Alzheimer’s disease

Different peripheral expression patterns of the nicotinic acetylcholine receptor in dementia with Lewy bodies and Alzheimer’s disease

Aβ43 in human Alzheimer’s disease: effects of active Aβ42 immunization

Aβ43 in human Alzheimer’s disease: effects of active Aβ42 immunization

(-)-(18F)NCFHEB-PET in Alzheimer's disease : relationship between nicotinic receptor availability and cognition

Hochschulschrift

(-)-(18F)NCFHEB-PET in Alzheimer's disease : relationship between nicotinic receptor availability and cognition

Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer’s Disease

Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer’s Disease

Alzheimer’s Disease

Alzheimer’s Disease

Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer’s disease pathogenesis

Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer’s disease pathogenesis

Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice

Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice

Related objects